Microbial Drug Resistance

metrics 2024

Uniting Disciplines to Tackle Microbial Threats

Introduction

Microbial Drug Resistance, published by MARY ANN LIEBERT, INC, is a pivotal journal that explores the critical intersection of microbiology and pharmacology with a keen focus on antibiotic resistance and related issues. Since its inception in 1995, this journal has established itself as a vital resource for researchers, healthcare professionals, and students, offering a platform for innovative studies that inform the global response to antimicrobial resistance. With a commendable position in the Category Quartiles, ranked Q2 in Medicine (miscellaneous) and Q2 in Pharmacology for 2023, it caters to a multidisciplinary audience by addressing the implications of microbial resistance within various medical contexts. Although currently non-Open Access, the journal allows subscribers and institutions to access high-quality, peer-reviewed research, directly impacting policy and practice in healthcare settings. Committed to advancing our understanding and combating the challenges posed by resistant microbes, Microbial Drug Resistance remains an essential publication in the fields of microbiology, immunology, and pharmacology.

Metrics 2024

SCIMAGO Journal Rank0.60
Journal Impact Factor2.30
Journal Impact Factor (5 years)3.50
H-Index78
Journal IF Without Self2.30
Eigen Factor0.00
Normal Eigen Factor0.88
Influence0.73
Immediacy Index0.40
Cited Half Life5.50
Citing Half Life7.60
JCI0.57
Total Documents2226
WOS Total Citations4092
SCIMAGO Total Citations17477
SCIMAGO SELF Citations862
Scopus Journal Rank0.60
Cites / Document (2 Years)2.40
Cites / Document (3 Years)2.43
Cites / Document (4 Years)2.54

Metrics History

Rank 2024

Scopus

Pharmacology in Pharmacology, Toxicology and Pharmaceutics
Rank #119/313
Percentile 61.98
Quartile Q2
Microbiology (medical) in Medicine
Rank #56/140
Percentile 60.00
Quartile Q2
Microbiology in Immunology and Microbiology
Rank #79/182
Percentile 56.59
Quartile Q2
Immunology in Immunology and Microbiology
Rank #121/236
Percentile 48.73
Quartile Q3

IF (Web Of Science)

INFECTIOUS DISEASES
Rank 81/132
Percentile 39.00
Quartile Q3
MICROBIOLOGY
Rank 109/161
Percentile 32.60
Quartile Q3
PHARMACOLOGY & PHARMACY
Rank 199/354
Percentile 43.90
Quartile Q3

JCI (Web Of Science)

INFECTIOUS DISEASES
Rank 69/132
Percentile 47.73
Quartile Q3
MICROBIOLOGY
Rank 90/161
Percentile 44.10
Quartile Q3
PHARMACOLOGY & PHARMACY
Rank 210/354
Percentile 40.68
Quartile Q3

Quartile History

Similar Journals

JOURNAL OF CLINICAL MICROBIOLOGY

Unveiling Innovations in Clinical Microbiology
Publisher: AMER SOC MICROBIOLOGYISSN: 0095-1137Frequency: 12 issues/year

JOURNAL OF CLINICAL MICROBIOLOGY, published by the American Society for Microbiology, stands as a premier resource for researchers and professionals in the field of medical microbiology. With an illustrious history dating back to 1975, this journal has consistently provided high-impact research, reflecting its status in the Q1 category among microbiology (medical) journals, and an impressive Scopus rank of 14 out of 140, placing it in the 90th percentile. The journal's commitment to unveiling foundational and innovative studies greatly contributes to understanding human health challenges posed by microbial pathogens. Researchers can expect rigorous peer-reviewed articles that cover a spectrum of topics, from diagnostic methods to clinical epidemiology, fostering a deeper understanding of microbiology's role in healthcare. While this journal does not offer open access options, its substantial impact factor underscores its relevance in shaping the conversation in clinical microbiology. The JOURNAL OF CLINICAL MICROBIOLOGY is indispensable for anyone dedicated to advancing their knowledge and practical skills in microbiology.

Infection and Drug Resistance

Transforming public health discourse on infectious diseases.
Publisher: DOVE MEDICAL PRESS LTDISSN: 1178-6973Frequency: 1 issue/year

Infection and Drug Resistance, published by DOVE MEDICAL PRESS LTD, is a leading open-access journal dedicated to the critical fields of infectious diseases and pharmacology. Since its establishment in 2008, this journal has emerged as a vital resource for researchers, professionals, and students alike, offering thorough insights into the mechanisms of drug resistance and the effectiveness of various therapeutic interventions. With an impressive 2023 impact factor placing it in the Q2 category across multiple relevant disciplines, including Infectious Diseases and Pharmacology, it serves as a significant platform for high-quality research dissemination. Infection and Drug Resistance aims to foster a deeper understanding of the evolving challenges in managing infectious diseases and enhancing drug efficacy, contributing to the global discourse on public health. The journal's commitment to open access ensures that vital knowledge is readily available to promote broader scholarly engagement and innovation.

Expert Review of Anti-Infective Therapy

Navigating the Frontiers of Infectious Disease Solutions
Publisher: TAYLOR & FRANCIS LTDISSN: 1478-7210Frequency: 12 issues/year

Expert Review of Anti-Infective Therapy, published by Taylor & Francis Ltd, is a leading journal in the field of infectious diseases, microbiology, and virology, boasting an impressive impact factor and ranking in the Q1 category across multiple disciplines. With an ISSN of 1478-7210 and E-ISSN 1744-8336, this journal has become a vital resource for researchers, professionals, and students aiming to advance their understanding of anti-infective therapies. Since its inception in 2003, the journal has provided critical insights, evidence-based reviews, and forward-thinking perspectives that contribute significantly to the ongoing efforts in combating infectious diseases. As of 2023, it ranks #36 out of 344 in Medicine/Infectious Diseases and maintains high percentiles in various other categories, reflecting its influence and reach within the scientific community. Although not an Open Access journal, its rich content is delivered through various academic libraries, sustaining its commitment to disseminating knowledge in the face of global health challenges. For those committed to innovation in the field, the Expert Review of Anti-Infective Therapy offers a platform that blends thorough research with practical applications, making significant strides in the fight against infectious pathogens.

International Journal of Antimicrobial Agents

Shaping the Future of Antimicrobial Treatments
Publisher: ELSEVIERISSN: 0924-8579Frequency: 12 issues/year

International Journal of Antimicrobial Agents, published by Elsevier, stands as a premier platform in the fields of Infectious Diseases, Microbiology, and Medical Pharmacology. With an impressive impact factor and ranked in the Q1 category across multiple medical disciplines in 2023, this journal is recognized for its contribution to advancing knowledge and understanding in the efficacy and safety of antimicrobial treatments. Its comprehensive scope from 1991 to 2024 allows for the publishing of original research, reviews, and commentary on pressing issues related to antimicrobial resistance, treatment strategies, and pharmacological innovations. With a strong emphasis on high-quality research as reflected in its Scopus rankings, the journal is an essential resource for researchers, clinicians, and students dedicated to improving patient outcomes in the face of evolving microbiological challenges. Engage with the latest findings and methodologies through this vital academic resource, available in print and online, from the heart of the Netherlands.

Indian Journal of Medical Microbiology

Advancing the Frontiers of Medical Microbiology
Publisher: ELSEVIERISSN: 0255-0857Frequency: 4 issues/year

Indian Journal of Medical Microbiology, published by Elsevier, is a pivotal peer-reviewed journal dedicated to the field of medical microbiology, providing a vital platform for research and scholarship since its inception in 1986. With an Open Access model established in 2001, it ensures the dissemination of scientific knowledge to a global audience, enhancing accessibility for researchers, professionals, and students alike. The journal's scope spans critical areas including immunology, infectious diseases, and microbiology, with an impressive trajectory marked by converged years of publication allowing for a comprehensive exploration of evolving scientific trends. As of 2023, the journal holds a Q3 ranking in Infectious Diseases and Microbiology (medical) and a Q4 ranking in Immunology and Microbiology categories, reflecting its significant yet growing impact in the field. Researchers seeking to contribute to or stay updated on the latest advancements in medical microbiology will find the Indian Journal of Medical Microbiology a valuable resource, as it consistently bridges the gap between emerging science and clinical application.

INDIAN JOURNAL OF MICROBIOLOGY

Elevating Microbial Studies to New Heights
Publisher: SPRINGERISSN: 0046-8991Frequency: 4 issues/year

INDIAN JOURNAL OF MICROBIOLOGY, published by Springer, serves as a vital platform for the dissemination of cutting-edge research in the field of microbiology. With an ISSN of 0046-8991 and an E-ISSN of 0973-7715, this esteemed journal invites contributions that span various disciplines within microbiology, encompassing both fundamental studies and applied research that can impact health, environment, and industry. Recognized in the Q3 category in Microbiology for 2023, and ranking #80 out of 182 in Scopus’ Microbiology category, it reflects its commitment to quality and significance in the academic community. Authors and researchers benefit from the journal's comprehensive review process, which enhances the visibility and reach of their work. While no open access options are currently offered, the INDIAN JOURNAL OF MICROBIOLOGY remains a premier choice for those aiming to contribute to the ongoing dialogue in microbiological studies, ensuring that knowledge continues to evolve and thrive.

CRITICAL REVIEWS IN MICROBIOLOGY

Synthesizing Expertise for a Deeper Understanding
Publisher: TAYLOR & FRANCIS LTDISSN: 1040-841XFrequency: 4 issues/year

CRITICAL REVIEWS IN MICROBIOLOGY, published by Taylor & Francis Ltd, is a leading peer-reviewed journal that has made significant contributions to the field of microbiology since its inception in 1971. With a prestigious Q1 ranking in Applied Microbiology and Biotechnology, as well as in Medicine and Microbiology, this journal is recognized for its high-quality reviews that synthesize current research and emerging trends in the discipline. Researchers and professionals rely on its comprehensive evaluations and critical insights, helping to advance knowledge and application in various microbiological contexts. Although the journal does not currently operate under an open access model, it remains an invaluable resource for academics seeking to stay at the forefront of microbiological advances. With a consistent publication record, CRITICAL REVIEWS IN MICROBIOLOGY continues to support the scholarly community by addressing key issues and innovations within the field.

Emerging Microbes & Infections

Pioneering discoveries in microbial health.
Publisher: TAYLOR & FRANCIS LTDISSN: Frequency: 1 issue/year

Emerging Microbes & Infections is a premier open access journal, published by Taylor & Francis Ltd since 2012, dedicated to advancing the understanding of microbial infections and their implications in human health. With an impressive Q1 ranking across multiple categories—including Drug Discovery, Epidemiology, Immunology, and Infectious Diseases—this journal is at the forefront of research in the microbiological sciences. Covering a diverse range of topics, it serves as a vital resource for researchers, healthcare professionals, and students alike. The journal's commitment to open access ensures worldwide dissemination of cutting-edge findings, fostering collaboration and innovation in tackling challenges posed by emerging infections. As part of the thriving academic community in the United Kingdom, Emerging Microbes & Infections plays a crucial role in shaping the future of infectious disease research and public health.

Mediterranean Journal of Infection Microbes and Antimicrobials

Fostering global collaboration on microbial challenges.
Publisher: GALENOS PUBL HOUSEISSN: 2147-673XFrequency: 1 issue/year

Mediterranean Journal of Infection Microbes and Antimicrobials is a distinguished open-access journal published by GALENOS PUBL HOUSE, dedicated to advancing the understanding of infectious diseases and microbiology. Since its inception in 2011, this journal has been a vital resource for researchers, professionals, and students interested in the intricate world of microbes and their impacts on human health. With its ISSN 2147-673X, the journal has progressively gained visibility, although it currently holds a Q4 ranking in multiple categories including Immunology and Microbiology, and Infectious Diseases for the year 2023. The journal operates from its headquarters in Istanbul, Turkey, and features a rich array of articles that contribute to the field’s body of knowledge. As a platform enhancing the accessibility of research, it invites submissions from global contributors to foster collaboration and innovation in tackling microbial challenges.

Journal of Global Antimicrobial Resistance

Connecting researchers to tackle the resistance crisis.
Publisher: ELSEVIER SCI LTDISSN: 2213-7165Frequency: 4 issues/year

The Journal of Global Antimicrobial Resistance, published by Elsevier Scientific Ltd, is a premier open access journal dedicated to addressing the critical issue of antimicrobial resistance on a global scale. Established in 2013 and significantly gaining traction as an open access platform since 2020, this journal serves as an essential resource for researchers, healthcare professionals, and policy makers invested in immunology, microbiology, and associated fields. With an impressive impact factor reflected through its consistent ranking in the Q2 category across multiple disciplines, including Microbiology and Immunology – where it ranks #29 out of 140 in Medical Microbiology – the journal ensures high-quality peer-reviewed articles that push the boundaries of current knowledge and practice. By offering a global perspective on research trends and public health implications, the Journal of Global Antimicrobial Resistance plays a pivotal role in advancing the scientific discourse necessary to combat the rising tide of antimicrobial resistance worldwide.